These Three Toilets Detection Health Technologies Will Be Clinically Tested In The US, Israel And Japan

These Three Toilets Detection Health Technologies Will Be Clinically Tested In The US, Israel And Japan

Israeli digital health startup OutSense has been awarded a number of patents for key innovations in IoT technology, according to foreign media reports on 23 六月. The technology gains life-saving medical insights by analysing human excrement. 該公司已申請了一系列三項專利，涵蓋其醫用廁所傳感器的元件.

Three Toilets Detection Health Technologies

The first OutSense toilets detection health technologies is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet to determine the optical signature of hidden blood in faeces. Patents for this technology have been granted in the US, 歐洲, 日本和中國.

A second toilets detection health technologies has been granted in Europe and applications for this patent are pending in other countries. It allows effective analysis of the many components of faeces and the spatial distribution of blood traces. On the basis of this analysis, OutSense 的技術可以識別胃腸道的血液來源.

A third patent is pending for a technology that detects the dehydrated composition of urine through the analysis of urine and faeces.

OutSense 首席執行官 Yfat Scialom 表示, who predicts that “隨著數字醫學的爆炸式增長, this kind of monitoring will become the norm”, OutSense says that the technology already approved and pending approval will provide broad protection for a person’s health by non-invasively extracting faeces and hidden blood from the urine. Hidden blood is essential for detecting colorectal cancer, 炎症性腸病和尿路感染.

Its solution consists of a multispectral optical sensor, 光源和包含 WiFi 連接的自主篩選設備. The device scans human excrement, identifies the optical footprint of faecal and urine components, sends the data to an AI-based cloud analysis and then provides indications of various diseases with great precision.

OutSense has developed tools to diagnose abnormalities in human excreta. 從血液樣本中獲得的信息, 結合從出血到排泄的時間的附加分析, 提供出血病理學的詳細信息. Its specific patterns can determine whether the bleeding is from a fissure or haemorrhoid, from a polyp, a tumour or from an ulcer.

At the beginning of June, OutSense 宣布 CommuniCare, 一家大型醫療保健公司，擁有超過 90 healthcare facilities in the US, 將於今年開始試點其技術. 除了這個試點, OutSense also plans to conduct clinical trials in Israel and Japan.

訪問更多新聞： Viga.cc新聞